Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Avai Bio (AVAI) EBITDA Margin (2019 - 2020)

Avai Bio's EBITDA Margin history spans 2 years, with the latest figure at 278.81% for Q4 2020.

  • For Q4 2020, EBITDA Margin changed N/A year-over-year to 278.81%; the TTM value through Dec 2022 reached 423.52%, changed N/A, while the annual FY2025 figure was 292.34%, 1914008.0% down from the prior year.
  • EBITDA Margin for Q4 2020 was 278.81% at Avai Bio, up from 24.57% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 278.81% in Q4 2020 and bottomed at 208.85% in Q2 2019.